European Medicines Agency

We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

In the last 7 days

EU clinical trial advice pilot becomes permanent Clinical Trials Arena17:20 9-Oct-26

Biocon’s Pertuzumab Biosimilar Receives Positive CHMP Opinion Under EMA’s Tailored Clinical Approach JD Supra21:25 8-Oct-26

Scholar Rock Revives European Filing For SMA Therapy After U.S. Approval RTT News15:20 8-Oct-26

Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (Maa) to European… Business Wire (Press Release)13:07 8-Oct-26

HLB says bile duct cancer drug lirafugratinib enters full review for European approval Asia Today08:36 7-Oct-26

Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc. Business Wire (Press Release)13:07 5-Oct-26

Missing women in the medicine map The Hindu Business Line02:16 5-Oct-26

In the last month

Ultragenyx Pharmaceutical (RARE) Could Be 42% Undervalued On EMA Filing Progress Simply Wall St16:07 3-Oct-26

Ultragenyx's Mps Iiia Gene Therapy Application Validated By EMA RTT News12:22 2-Oct-26

Rznomics Receives Positive Opinion for Orphan Medicinal Product Designation of RZ-001 for Glioma PR Newswire (Press Release)10:37 30-Sept-26

EMA approves Oryzon’s application for Phase II HOPE-2 study Clinical Trials Arena12:15 29-Sept-26

How the European Medicines Agency handled a complaint concerning reactivation of an account in… The European Ombudsman (Press Release)09:02 29-Sept-26

Brc Therapeutics Joins FDA and EMA Regulators at Workshop Advancing the Future of Botanical… PR Newswire (Press Release)16:48 28-Sept-26

Biocon Malaysia gets UK Mhra approval for new drug product fill-finish unit for insulins The Hindu Business Line10:53 25-Sept-26

Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product… PR Newswire (Press Release)15:00 22-Sept-26

Biocon's Pertuzumab Becomes First Biosimilar to Secure EMA Chmp Approval Recommendation Under… PR Newswire (Press Release)12:59 22-Sept-26

FDA reviewing contraceptives tied to meningioma risk Taipei Times10:13 21-Sept-26

Biocon arm gets positive EMA panel recommendation for breast cancerbiosimilar Pebrilzo The Economic Times09:10 21-Sept-26

Biocon spurts 3% as Pertuzumab drug moves closer to marketing nod in Europe The Business Standard06:51 21-Sept-26

Biocon gains as Pertuzumab biosimilar gets positive EMA recommendation The Business Standard06:41 21-Sept-26

Taiwan drug regulator reassessing safety of contraceptives linked to tumors Focus Taiwan06:28 21-Sept-26

Biocon's Pertuzumab gets EMA Chmp recommendation for breast cancer care The Business Standard06:07 21-Sept-26

Biocon Biologics receives positive Chmp opinion for Pertuzumab biosimilar The Business Standard05:09 21-Sept-26

EMA backs 12 new medicines, alongside key label expansions EU Reporter10:09 19-Sept-26

Novo’s once-weekly Sogroya® (somapacitan) receives positive CHMP opinion in Europe for children with idiopathic short… Novo Nordisk11:54 18-Sept-26

EMA Committee Endorses Novo Nordisk's Hemophilia A Therapy Benzinga17:49 17-Sept-26

view more headlines

9 Oct 17:20

Don't miss out! Get the day's top headlines delivered to your inbox

About our EMA news

Latest news on the European Medicines Agency, also known as the EMA, a European Union agency responsible for the evaluation and supervision of pharmaceuticals.

European Medicines Agency

About our EMA news

European Union Top Stories

Europe Top Stories

World Top Stories